CoChat

A rat RNA-Seq transcriptomic BodyMap across 11 organs and 4 developmental stages

Open access

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Abstract

The rat has been used extensively as a model for evaluating chemical toxicities and for understanding drug mechanisms. However, its transcriptome across multiple organs, or developmental stages, has not yet been reported. Here we show, as part of the SEQC consortium efforts, a comprehensive rat transcriptomic BodyMap created by performing RNA-Seq on 320 samples from 11 organs of both sexes of juvenile, adolescent, adult and aged Fischer 344 rats. We catalogue the expression profiles of 40,064 genes, 65,167 transcripts, 31,909 alternatively spliced transcript variants and 2,367 non-coding genes/non-coding RNAs (ncRNAs) annotated in AceView. We find that organ-enriched, differentially expressed genes reflect the known organ-specific biological activities. A large number of transcripts show organ-specific, age-dependent or sex-specific differential expression patterns. We create a web-based, open-access rat BodyMap database of expression profiles with crosslinks to other widely used databases, anticipating that it will serve as a primary resource for biomedical research using the rat model. Gene expression is highly variable between tissues, and changes during development and with age. Here, the authors provide a comprehensive RNA-Seq analysis of the rat transcriptome, spanning eleven organs, four developmental stages and both sexes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms4230

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Landscape of the rat RNA-Seq transcriptome. Number of expressed genes (a) and transcripts (b) detected per organ across four developmental stages in both males and females (4 biological replicates each). For each panel (a,b), the x axis indicates organs and developmental stages in either sex, whereas the y axes (left and right) indicate the numbers of genes or transcripts expressed (× 1,000; left) or the percentages of all annotated genes or transcripts (right) in each organ across four developmental stages in either sex. Red bars represent the number of expressed genes or transcripts (mean±s.e., N=8; for Tst and Utr N=4) annotated in both RefSeq and AceView, while blue bars represent the additional expressed genes or transcripts (mean±s.e., N=8; for Tst and Utr N=4) annotated only in AceView. The green lines (unions) represent the number of genes or transcripts expressed per organ and per age in at least one biological replica, male or female (N=8). A gene or transcript was considered expressed if its average expression level in FPKM is 1. (c) Hierarchical clustering analysis of gene expression profiles from 320 rat samples with 40,064 genes. (d) Principal variance component analysis (PVCA) of the relative contribution of main effects (organ, age, sex and replicate) and their combinations (asterisk) to total model variance. RefSeq genes are characterized by a gene ID; for RefSeq transcripts, only those well annotated (that is, with ‘NM_’ accessions) were counted. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus; Inter: intersection of genes (a) and transcripts (b) commonly expressed across all 11 organs sampled in this study.
Figure 1 Landscape of the rat RNA-Seq transcriptome. Number of expressed genes (a) and transcripts (b) detected per organ across four developmental stages in both males and females (4 biological replicates each). For each panel (a,b), the x axis indicates organs and developmental stages in either sex, whereas the y axes (left and right) indicate the numbers of genes or transcripts expressed (× 1,000; left) or the percentages of all annotated genes or transcripts (right) in each organ across four developmental stages in either sex. Red bars represent the number of expressed genes or transcripts (mean±s.e., N=8; for Tst and Utr N=4) annotated in both RefSeq and AceView, while blue bars represent the additional expressed genes or transcripts (mean±s.e., N=8; for Tst and Utr N=4) annotated only in AceView. The green lines (unions) represent the number of genes or transcripts expressed per organ and per age in at least one biological replica, male or female (N=8). A gene or transcript was considered expressed if its average expression level in FPKM is 1. (c) Hierarchical clustering analysis of gene expression profiles from 320 rat samples with 40,064 genes. (d) Principal variance component analysis (PVCA) of the relative contribution of main effects (organ, age, sex and replicate) and their combinations (asterisk) to total model variance. RefSeq genes are characterized by a gene ID; for RefSeq transcripts, only those well annotated (that is, with ‘NM_’ accessions) were counted. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus; Inter: intersection of genes (a) and transcripts (b) commonly expressed across all 11 organs sampled in this study.CC BY-NC-ND · PubMed Central
Figure 2 Organ- and development-dependent and sex-specific genes. (a) Comparison of relative gene expression between organs. Circos plot illustrating the relative number of DEGs between any two organs (orange, overexpressed; green, underexpressed). Concentric circles from inside to outside represent; A, organ under comparison (colour-coded as described in the outer-most ring); B, the 11 organs being compared with organ A (note no change in DEGs for organ compared with itself); C–F, total number of DEGs, more (orange) or fewer (green) in organ A versus the other organs at weeks 2 (C), 6 (D), 21 (E) or 104 (F). Each bar represents the combination of either four or eight biological replicates for a given organ at the same developmental stage. A gene was considered differentially expressed between two organs if the fold change was 2 or 0.5 (t-test, P-value 0.05). (b) Expression profiles of organ-enriched genes with corresponding significantly and uniquely enriched GeneGo canonical pathway maps. Expression data for 3,413 organ-enriched genes across 320 samples were arranged by organ type (in decreasing order in terms of the number of organ-enriched genes), sex and developmental stage. (c) Development-dependent clusters with significantly enriched GeneGo canonical pathway maps. Development-dependent genes in each organ were identified using a combination of ANOVA with Bonferroni-corrected P0.05 plus a FC2. Hierarchical clustering analysis grouped the development-dependent genes into 10 clusters. (d) Sex-specific clusters with significantly enriched GeneGo canonical pathway maps. The 288 samples (except uterus and testis samples) were separated into 36 groups based on four developmental stages and nine organ types. For any organ at any development stage, genes with a FC2 (or 0.5) and P0.05 between female and male were considered sex-specific. Hierarchical clustering analysis grouped the sex-specific genes into six clusters. Expression data were Z-score standardized (mean zero and s.d. of one) per gene. Ontology terms of enriched GeneGo canonical pathway maps were listed next to each organ type (b) or cluster (c,d) on the right along with –log10(FDR q-value) in the parentheses. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.
Figure 2 Organ- and development-dependent and sex-specific genes. (a) Comparison of relative gene expression between organs. Circos plot illustrating the relative number of DEGs between any two organs (orange, overexpressed; green, underexpressed). Concentric circles from inside to outside represent; A, organ under comparison (colour-coded as described in the outer-most ring); B, the 11 organs being compared with organ A (note no change in DEGs for organ compared with itself); C–F, total number of DEGs, more (orange) or fewer (green) in organ A versus the other organs at weeks 2 (C), 6 (D), 21 (E) or 104 (F). Each bar represents the combination of either four or eight biological replicates for a given organ at the same developmental stage. A gene was considered differentially expressed between two organs if the fold change was 2 or 0.5 (t-test, P-value 0.05). (b) Expression profiles of organ-enriched genes with corresponding significantly and uniquely enriched GeneGo canonical pathway maps. Expression data for 3,413 organ-enriched genes across 320 samples were arranged by organ type (in decreasing order in terms of the number of organ-enriched genes), sex and developmental stage. (c) Development-dependent clusters with significantly enriched GeneGo canonical pathway maps. Development-dependent genes in each organ were identified using a combination of ANOVA with Bonferroni-corrected P0.05 plus a FC2. Hierarchical clustering analysis grouped the development-dependent genes into 10 clusters. (d) Sex-specific clusters with significantly enriched GeneGo canonical pathway maps. The 288 samples (except uterus and testis samples) were separated into 36 groups based on four developmental stages and nine organ types. For any organ at any development stage, genes with a FC2 (or 0.5) and P0.05 between female and male were considered sex-specific. Hierarchical clustering analysis grouped the sex-specific genes into six clusters. Expression data were Z-score standardized (mean zero and s.d. of one) per gene. Ontology terms of enriched GeneGo canonical pathway maps were listed next to each organ type (b) or cluster (c,d) on the right along with –log10(FDR q-value) in the parentheses. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.CC BY-NC-ND · PubMed Central
Figure 3 Development-dependent patterns of rat gene expression. (a) Differentially expressed genes were determined based on a combination of ANOVA with the Bonferroni-corrected P-value 0.05 and FC2 (or 0.5) between the four developmental stages. For each organ, data from two sequential developmental stages were compared, with the younger developmental stage used as the denominator. Genes were grouped into Up (U; ‘upregulated’ based on FC2), Down (D; ‘downregulated’ based on FC0.5), or Maintain (M; ‘no change’ based on 0.5<FC<2). Shown here are the 27 possible combinatorial patterns. The x axis depicts time point (in weeks) and the y axis depicts fold change. The number shown in each box (for example, 129 genes for pattern DDD) was derived based on the number of genes, across all 11 organs—where each gene was counted only once regardless of how many organs shared that same pattern. (b) The percentage of genes within each pattern per organ exhibiting specific development-dependent expression patterns. The numbers in the table are colour-coded; red indicates a relatively large percentage of genes with that expression pattern and blue represents a relatively small percentage of genes with that pattern. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.
Figure 3 Development-dependent patterns of rat gene expression. (a) Differentially expressed genes were determined based on a combination of ANOVA with the Bonferroni-corrected P-value 0.05 and FC2 (or 0.5) between the four developmental stages. For each organ, data from two sequential developmental stages were compared, with the younger developmental stage used as the denominator. Genes were grouped into Up (U; ‘upregulated’ based on FC2), Down (D; ‘downregulated’ based on FC0.5), or Maintain (M; ‘no change’ based on 0.5<FC<2). Shown here are the 27 possible combinatorial patterns. The x axis depicts time point (in weeks) and the y axis depicts fold change. The number shown in each box (for example, 129 genes for pattern DDD) was derived based on the number of genes, across all 11 organs—where each gene was counted only once regardless of how many organs shared that same pattern. (b) The percentage of genes within each pattern per organ exhibiting specific development-dependent expression patterns. The numbers in the table are colour-coded; red indicates a relatively large percentage of genes with that expression pattern and blue represents a relatively small percentage of genes with that pattern. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.CC BY-NC-ND · PubMed Central
Figure 4 Sex differences of rat transcriptomic profiles. Gene expression values, expressed as log2FPKM, for male (y axis) and female (x axis) rats are depicted in the scatter plots. These plots show gene expression profiles between female and male rats in nine organs (a) and four developmental stages (b) using pooled data from either all four stages (a) or all organs for a given stage (b). Non-DEGs form the centre line (in grey), while DEGs are coloured and occur above and below the centre line. 002=2 weeks; 006=6 weeks; 021=21 weeks; 104=104 weeks. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; and Thm, thymus.
Figure 4 Sex differences of rat transcriptomic profiles. Gene expression values, expressed as log2FPKM, for male (y axis) and female (x axis) rats are depicted in the scatter plots. These plots show gene expression profiles between female and male rats in nine organs (a) and four developmental stages (b) using pooled data from either all four stages (a) or all organs for a given stage (b). Non-DEGs form the centre line (in grey), while DEGs are coloured and occur above and below the centre line. 002=2 weeks; 006=6 weeks; 021=21 weeks; 104=104 weeks. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; and Thm, thymus.CC BY-NC-ND · PubMed Central
Figure 5 Organ-enriched alternatively spliced transcript expression. (a) Numbers of organ-specific transcript variants for both female and male rats across the four developmental stages. A transcript was considered an organ-specific alternatively spliced variant if it had an FC2 plus a Bonferroni-corrected P-value 0.05 when compared with its expression in other organs across the four developmental stages. (b) Organ-specific transcript variant abundance. Distribution of genes (on the right) with a given number of variants (1 thru 10). (c) Organ-specific transcript variant expression for Dlg2. The y axis represents normalized (Mean=0 and s.d.=1) expression profile (mean±s.e., N=32 (or 16 for Tst and Utr)) Z-score and the x axis represents Dlg2 gene (green), Dlg2.b variant (orange) and Dlg2.e variant (blue) expression in each organ. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.
Figure 5 Organ-enriched alternatively spliced transcript expression. (a) Numbers of organ-specific transcript variants for both female and male rats across the four developmental stages. A transcript was considered an organ-specific alternatively spliced variant if it had an FC2 plus a Bonferroni-corrected P-value 0.05 when compared with its expression in other organs across the four developmental stages. (b) Organ-specific transcript variant abundance. Distribution of genes (on the right) with a given number of variants (1 thru 10). (c) Organ-specific transcript variant expression for Dlg2. The y axis represents normalized (Mean=0 and s.d.=1) expression profile (mean±s.e., N=32 (or 16 for Tst and Utr)) Z-score and the x axis represents Dlg2 gene (green), Dlg2.b variant (orange) and Dlg2.e variant (blue) expression in each organ. Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.CC BY-NC-ND · PubMed Central
Figure 6 Alternative polyadenylation variants. (a) An example of alternative splicing and polyadenylation. The upper panel of (a) shows the alternate variants c and d of gene Tnni1, both encoding the same protein isoform of troponin 1, skeletal, slow 1. A white thin box represents a UTR, whereas pink means a protein-coding region, and the solid black and blue flags in the 3′-UTRs represent the canonical and non-canonical poly-A signals used for polyadenylation, respectively. The expression levels of these two transcripts in brain (Brn), skeletal muscle (Msc) and thymus (Thm) of female (F) rats at week 6 (006) are shown in barplots, with error bars representing the s.e. of expression values (log2FPKM) across the four biological replicates. (b,c) Two examples of co-expression-based functional prediction. Each example includes the expression values (log2FPKM) of two genes, one with annotated functions (blue) and the other without (red) across the 80 sample groups ordered first by organ, then by sex (except for testis and uterus) and at last by age. The GO term shown for each example represents the function of the annotated gene (Nat1/Nat2 or Avpr1a) and is the predicted function of the corresponding non-annotated gene (spliced non-coding gene muwey or spliced coding gene gaflo). Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.
Figure 6 Alternative polyadenylation variants. (a) An example of alternative splicing and polyadenylation. The upper panel of (a) shows the alternate variants c and d of gene Tnni1, both encoding the same protein isoform of troponin 1, skeletal, slow 1. A white thin box represents a UTR, whereas pink means a protein-coding region, and the solid black and blue flags in the 3′-UTRs represent the canonical and non-canonical poly-A signals used for polyadenylation, respectively. The expression levels of these two transcripts in brain (Brn), skeletal muscle (Msc) and thymus (Thm) of female (F) rats at week 6 (006) are shown in barplots, with error bars representing the s.e. of expression values (log2FPKM) across the four biological replicates. (b,c) Two examples of co-expression-based functional prediction. Each example includes the expression values (log2FPKM) of two genes, one with annotated functions (blue) and the other without (red) across the 80 sample groups ordered first by organ, then by sex (except for testis and uterus) and at last by age. The GO term shown for each example represents the function of the annotated gene (Nat1/Nat2 or Avpr1a) and is the predicted function of the corresponding non-annotated gene (spliced non-coding gene muwey or spliced coding gene gaflo). Organs tested are: Adr, adrenal; Brn, brain; Hrt, heart; Kdn, kidney; Lng, lung; Lvr, liver; Msc, skeletal muscle; Spl, spleen; Thm, thymus; Tst, testis; and Utr, uterus.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 410

Metadata

Authors
Yu, Y., Fuscoe, J. C., Zhao, C., Guo, C., Jia, M., Qing, T., Bannon, D. I., Lancashire, L., Bao, W., Du, T., Luo, H., Su, Z., Jones, W. D., Moland, C. L., Branham, W. S., Qian, F., Ning, B., Li, Y., Hong, H., Guo, L., Mei, N., Shi, T., Wang, K. Y., Wolfinger, R. D., Nikolsky, Y., Walker, S. J., Duerksen-Hughes, P., Mason, C. E., Tong, W., Thierry-Mieg, J., Thierry-Mieg, D., Shi, L., & Wang, C.
Affiliations
  • Fudan University (CN)
  • National Center for Toxicological Research (US)
  • City Of Hope National Medical Center (US)
  • United States Army (US)
  • Thomson Reuters (United Kingdom) (GB)
  • SAS Institute (United States) (US)
  • Johns Hopkins University (US)
  • Wake Forest University Health Sciences (US)
  • Loma Linda University (US)
  • Cornell University (US)
Corresponding author
  • Shi, Leming
  • Wang, Charles
Venue
Nature Communications
Published
2014-02-10
Volume
5
Issue
1
Pages
3230-3230
ISSN
2041-1723 (ISSN-L)
OpenAlex
W1969885044
Cited by
395
References
43
Citations by year
2026: 15 · 2025: 15 · 2024: 30 · 2023: 40 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 34 · 2018: 30 · 2017: 32 · 2016: 33 · 2015: 22 · 2014: 8
FWCI
12.99
Type
journal article
Language
en
Open access
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Natural Science Foundation of China (11DZ2260300, 2010CB945401, 31071162)
  • Science and Technology Commission of Shanghai Municipality (31071162, 2010CB945401, 11DZ2260300)
  • National Institutes of Health
  • National Supercomputing Center of Tianjin
  • National Supercomputing Center, Korea Institute of Science and Technology Information
  • Office of Women's Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Phylogenetic Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
Keywords
organ-specific gene expression, developmental gene expression, aging, sex differences, alternative splicing, non-coding RNA, tissue expression profile, F344 rats
MeSH terms
Animals, Female, Male, Rats, Inbred F344, Sex Characteristics, Alternative Splicing, Sequence Analysis, RNA, Protein Isoforms, Gene Expression Profiling, Transcriptome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.